Literature DB >> 12032167

Characterization of the lipolytic activity of endothelial lipase.

Mary G McCoy1, Gwo-Shing Sun, Dawn Marchadier, Cyrille Maugeais, Jane M Glick, Daniel J Rader.   

Abstract

Endothelial lipase (EL) is a new member of the triglyceride lipase gene family previously reported to have phospholipase activity. Using radiolabeled lipid substrates, we characterized the lipolytic activity of this enzyme in comparison to lipoprotein lipase (LPL) and hepatic lipase (HL) using conditioned medium from cells infected with recombinant adenoviruses encoding each of the enzymes. In the absence of serum, EL had clearly detectable triglyceride lipase activity. Both the triglyceride lipase and phospholipase activities of EL were inhibited in a dose-dependent fashion by the addition of serum. The ratio of triglyceride lipase to phospholipase activity of EL was 0.65, compared with ratios of 24.1 for HL and 139.9 for LPL, placing EL at the opposite end of the lipolytic spectrum from LPL. Neither lipase activity of EL was influenced by the addition of apolipoprotein C-II (apoC-II), indicating that EL, like HL, does not require apoC-II for activation. Like LPL but not HL, both lipase activities of EL were inhibited by 1 M NaCl. The relative ability of EL, versus HL and LPL, to hydrolyze lipids in isolated lipoprotein fractions was also examined using generation of FFAs as an end point. As expected, based on the relative triglyceride lipase activities of the three enzymes, the triglyceride-rich lipoproteins, chylomicrons, VLDL, and IDL, were efficiently hydrolyzed by LPL and HL. EL hydrolyzed HDL more efficiently than the other lipoprotein fractions, and LDL was a poor substrate for all of the enzymes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032167

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  110 in total

1.  Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo.

Authors:  Tetsuya Hara; Tatsuro Ishida; Yoko Kojima; Hanayo Tanaka; Tomoyuki Yasuda; Masakazu Shinohara; Ryuji Toh; Ken-ichi Hirata
Journal:  J Lipid Res       Date:  2010-10-06       Impact factor: 5.922

2.  Determination of lipoprotein lipase activity using a novel fluorescent lipase assay.

Authors:  Debapriya Basu; Jahan Manjur; Weijun Jin
Journal:  J Lipid Res       Date:  2011-01-26       Impact factor: 5.922

Review 3.  Endothelial lipase: direct evidence for a role in HDL metabolism.

Authors:  Jonathan C Cohen
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 4.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 5.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

6.  Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase.

Authors:  Joanne M Wroblewski; Anisa Jahangiri; Ailing Ji; Frederick C de Beer; Deneys R van der Westhuyzen; Nancy R Webb
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

7.  Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.

Authors:  Michelle Bamji-Mirza; Meenakshi Sundaram; Shumei Zhong; Erik F Yao; Robin J Parks; Zemin Yao
Journal:  J Lipid Res       Date:  2010-12-27       Impact factor: 5.922

8.  Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species.

Authors:  Yanbo Yang; Takashi Kuwano; William R Lagor; Carolyn J Albert; Siobhan Brenton; Daniel J Rader; David A Ford; Robert J Brown
Journal:  Lipids       Date:  2014-04-29       Impact factor: 1.880

9.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

Authors:  Stefano Romeo; Wu Yin; Julia Kozlitina; Len A Pennacchio; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

10.  Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux.

Authors:  Martin Gauster; Olga V Oskolkova; Josef Innerlohinger; Otto Glatter; Gabriele Knipping; Sasa Frank
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.